Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Chimeric Therapeutics Ltd. ( (AU:CHM) ) has shared an announcement.
Chimeric Therapeutics Limited announced the quotation of 164,307,917 fully paid ordinary securities on the Australian Securities Exchange (ASX). This move is part of a previously announced transaction, which may enhance the company’s market presence and provide additional capital for its ongoing research and development efforts in cancer therapies.
More about Chimeric Therapeutics Ltd.
Chimeric Therapeutics Limited operates in the biotechnology industry, focusing on the development of innovative therapies. The company is primarily engaged in the research and development of cell therapies for cancer treatment, aiming to provide advanced solutions in oncology.
Technical Sentiment Signal: Sell
Current Market Cap: A$7.4M
Find detailed analytics on CHM stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue